SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-139299
Filing Date
2021-11-15
Accepted
2021-11-15 17:01:27
Documents
101
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 1866569
2 EXHIBIT 31.1 tmb-20210930xex31d1.htm EX-31.1 9465
3 EXHIBIT 31.2 tmb-20210930xex31d2.htm EX-31.2 9440
4 EXHIBIT 32 tmb-20210930xex32.htm EX-32 12236
  Complete submission text file 0001104659-21-139299.txt   8944279

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210930.xsd EX-101.SCH 91466
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210930_cal.xml EX-101.CAL 65734
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210930_def.xml EX-101.DEF 244328
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210930_lab.xml EX-101.LAB 603137
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210930_pre.xml EX-101.PRE 470911
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 1629515
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 211412073
SIC: 2834 Pharmaceutical Preparations